Nature Communications (Feb 2019)

Hematopoietic chimerism and donor-specific skin allograft tolerance after non-genotoxic CD117 antibody-drug-conjugate conditioning in MHC-mismatched allotransplantation

  • Zhanzhuo Li,
  • Agnieszka Czechowicz,
  • Amelia Scheck,
  • Derrick J. Rossi,
  • Philip M. Murphy

DOI
https://doi.org/10.1038/s41467-018-08202-w
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 7

Abstract

Read online

Transplantation of allogeneic bone marrow helps establish chimerism that may induce tolerance to tissue grafts. Here the authors show that a CD117-antibody-drug-conjugate helps precondition the recipients for inducing mixed chimerism and allo-tolerance without clear adverse effects or the need for chronic immune suppression.